在TAVR之后,贝叶斯对宁 - 血管素系统抑制剂的贝叶斯元分析
Vinícius Martins Rodrigues Oliveira1,2, Lucas M Barbosa3,4, Pedro Antônio de Sousa5
1Federal University of Goiás, Goiânia, Brazil.
概括
通过导管大动脉置换 (TAVR) 后的宁-血管素系统 (RAS) 抑制剂显著降低死亡率和心力衰竭再入院. 这种疗法在患有大动脉狭窄症的患者中改善心血管结果的可能性很高.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 医疗干预 医疗干预
背景情况:
- 大动脉狭窄导致有害的左心室重塑,增加心力衰竭的风险.
- 过导管大动脉置换 (TAVR) 改善了结果,但持续的并发症仍然存在.
- 氨酶系统 (RAS) 抑制剂可能在TAVR后提供保护作用.
研究的目的:
- 评估RAS抑制剂治疗对TAVR后临床结果的影响.
- 为优化TAVR后管理策略提供证据.
主要方法:
- 对12项涉及35,988名患者的研究进行了系统审查和贝叶斯元分析.
- 在接受TAVR的患者中,RAS抑制剂使用与不使用的比较.
- 使用贝叶斯随机效应模型估计的赔率比率和可信区间.
主要成果:
- 使用RAS抑制剂与79.4%降低所有原因死亡率和99.5%降低心血管死亡率的概率有关.
- 观察到,心力衰竭住院的可能性降低了54%.
- 发现对心肌梗塞发病率的影响微不足道.
结论:
- 在TAVR之后的RAS抑制剂治疗与显著降低的死亡率有关.
- 使用RAS抑制剂显示出与心力衰竭再入院减少的积极关联.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
Antihypertensive Drugs: Direct Renin Inhibitors
1.5K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.5K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.6K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.6K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Directing Effect of Substituents: meta-Directing Groups
6.0K
Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
6.0K
Hormonal Regulation
36.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.1K


